ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1138

Nailfold Capillaroscopy Findings in Patients with Idiopathic Inflammatory Myopathies and Its Association to Autoantibodies

Cristiana Sieiro Santos1, Jose Luis Tandaipan2, Anais Mariscal2, Luis Sainz-Comas2, Helena Codes2, Patricia Moya2, Berta Paula Magallares-Lopez3, Laura Martínez Martínez2, Ana Milena Millán Arciniegas2, Hye Sang Park2, César Díaz-Torné2, Ana Laíz Alonso2, Susana Fernández2, Sandra Ros2, Hector Corominas4, Elvira Díez Álvarez5 and Iván Castellvi2, 1Complejo Asistencial Universitario de León, León, Spain, 2Hospital de Santa Creu i Sant Pau, Barcelona, Spain, 3Department of Rheumatology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain, 4Hospital Universitario Sant Pau, Rheumatology, Barcelona, Spain, 5CAULE, León, Spain

Meeting: ACR Convergence 2023

Keywords: Autoantibody(ies), Myopathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1124–1154) Miscellaneous Rheumatic & Inflammatory Diseases Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of acquired muscle diseases, which have distinct clinical, pathological and histological features. Autoantibodies are clinically useful biomarkers to help the diagnosis of IIM. Raynaud’s phenomenon is very frequent and the presence of microvascular changes in IIM have been described however, the role of nailfold videocapillaroscopy NVC) for diagnosis and prognosis in IIM is not clearly established. The aim of this study was to study the relationship between clinical and immunological characteristics and nailfold videocapillaroscopy (NVC) abnormalities in patients with idiopathic inflammatory myopathies (IIMs).

Methods: We performed a retrospective study of IIM patients followed in a University Hospital. Patients underwent a NVC at 200x magnification. Epidemiological, clinical data and antibody status, including myositis and scleroderma antibody panel of all patients was retrieved. NVC findings including loss of capillary density, enlarged and giant capillaries, ramified capillaries, haemorrhages, thrombosis, avascular areas, disorganization of capillary architecture and subpapillary venous plexus presence were recollected, if present. For the comparison of qualitative and/or quantitative variables Fisher’s exact Test or T-test was performed when necessary.

Results: 95 patients with NVC performed during the follow-up were included (66% female) with a median age at inclusion of 55.3±24 years. Median IIM duration was 6.8±7 years. 39% had Raynaud’s phenomenon at first clinical evaluation and 58% of them showed NVC pathological findings. Table 1 Summarizes the epidemiological, clinical, and autoantibody status of the patients. We found an association between the presence of dysphagia and avascular areas (p=0.02) or abnormal capillary organization (p< 0.01) on NVC. ILD was associated with capillary loss (p=0.04) and avascular areas (p=0.004). Anti-MDA5+ was associated with capillary loss (p=0.03), thrombosis (p=0.02) and ramified capillaries (p=0.04). Anti-Mi2+ and anti-Th/To was associated with abnormal capillary organization (p=0.017 and p=0.001). The presence of haemorrhages was associated with anti-Ku+ (p=0.048) and anti-PL12+ (p=0.046). The presence of enlarged capillaries was associated with anti-RNA-pol III (p=0.04) and anti-NXP2 (p=0.044). A significant association between anti-Ro52 (OR 2.69, CI 95% 1.05-6.8, p 0.03) and anti-Jo1 (OR 7.03 CI 95% 1.46-33.7, p 0.01) with ILD was found. Anti-PML (OR 4.32 CI 95% 1.35-10.42, p 0.038) and anti-Th/To (OR 5.82 CI 95% 1.89-13.24, p 0.04) were associated with dysphagia. Anti-MDA5 (OR 5.85 CI 95% 1.92-14.21, p 0.044) was associated with skin involvement.

Conclusion: The presence of certain autoantibodies is related to the degree of microangiopathy in IIM and associates with capillaroscopic changes. Studying the association between capillaroscopic changes with diagnostic and pathogenic autoantibodies in IIM can provide useful information regarding the current knowledge about pathogenesis, classification, and prognosis of the disease.

Supporting image 1


Disclosures: C. Sieiro Santos: None; J. Tandaipan: None; A. Mariscal: None; L. Sainz-Comas: None; H. Codes: None; P. Moya: None; B. Magallares-Lopez: None; L. Martínez Martínez: None; A. Millán Arciniegas: None; H. Sang Park: None; C. Díaz-Torné: None; A. Laíz Alonso: None; S. Fernández: None; S. Ros: None; H. Corominas: None; E. Díez Álvarez: None; I. Castellvi: None.

To cite this abstract in AMA style:

Sieiro Santos C, Tandaipan J, Mariscal A, Sainz-Comas L, Codes H, Moya P, Magallares-Lopez B, Martínez Martínez L, Millán Arciniegas A, Sang Park H, Díaz-Torné C, Laíz Alonso A, Fernández S, Ros S, Corominas H, Díez Álvarez E, Castellvi I. Nailfold Capillaroscopy Findings in Patients with Idiopathic Inflammatory Myopathies and Its Association to Autoantibodies [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/nailfold-capillaroscopy-findings-in-patients-with-idiopathic-inflammatory-myopathies-and-its-association-to-autoantibodies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nailfold-capillaroscopy-findings-in-patients-with-idiopathic-inflammatory-myopathies-and-its-association-to-autoantibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology